Stock Watch / by - 26 days ago

CSL back in the buy zone

15 Jun 2020 - Fairmont Equities managing director Michael Gable takes a technical look S&P500, CSL, Resmed Inc and Bravura Solutions.

Company News / by Rachael Jones - A year ago

ResMed report NPAT up 15%

03 May 2019 - Health company, ResMed (ASX:RMD) released their results for the quarter ending 31 March 2019 showing NPAT up 15 per cent with income from operations at $157 million f…

Market Reports / by Rachael Jones - A year ago

Telstra up 7.8%: ASX closes 0.5% lower

29 Jan 2019 - The ASX failed to make major gains throughout the day and closed 0.5% lower or 31 points down to 5874. Telco services were leading the index today. Healthcare was the…

Interviews / by Jessica Amir - A year ago

2018 yearly wrap, the sweet and the sour

24 Dec 2018 - Bell Direct, Equity Strategist, Julia Lee and Fairmont Equities, Managing Director, Michael Gable talk about the macro issues plaguing markets, where growth has been …